Adragos Pharma Holding GmbH
Adragos Pharma Holding GmbH is a Private limited company (Ltd.) registered in Germany under HRB 282245 München, and its current status with Handelsregister (Commercial Register) is active. Its registered address on file is München, Germany. 5 shareholders are on record for Adragos Pharma Holding GmbH, including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO). This profile is sourced directly from Handelsregister (Commercial Register) and was last updated on 6 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for Adragos Pharma Holding GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG.
The largest of these is Four Invest S.à r.l., holding 37.4% — the largest recorded stake — followed by Four Invest S.à r.l. at 35.7%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 12 shareholders in total, though only the top 5 by holding are shown in this view.
2 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 3 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Four Invest S.à r.l. | 37.4% | Handelsregister (Commercial Register) | |
| Four Invest S.à r.l. | 35.7% | Handelsregister (Commercial Register) | |
| Prange Pharma GmbH | 17.4% | Handelsregister (Commercial Register) | |
| Prange Pharma GmbH | 2.6% | Handelsregister (Commercial Register) | |
| Four Invest S.à r.l. | 2.4% | Handelsregister (Commercial Register) |
Officers
5
Two of the 5 officer records shown for Adragos Pharma Holding GmbH are current appointments, filed with Handelsregister (Commercial Register). Andreas Raabe and Daniel Wigbers both serve as Geschäftsführer (managing director). The remaining 3 records shown (Philipp Dionys Eberhard Ziehr, Andreas Christian Raabe and 1 other) are former appointments that have since been resigned.
The register reports 6 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at Adragos Pharma Holding GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
Adragos Pharma Holding GmbH sits 2 levels below its ultimate parent, FSN CAPITAL VI L.P., registered in United Kingdom. 1 subsidiary is recorded beneath it, across 1 jurisdiction. The full chain up to FSN CAPITAL VI L.P. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by Adragos Pharma Holding GmbH's own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 1 subsidiary spans Germany jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
FSN CAPITAL VI L.P.
United Kingdom
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns Adragos Pharma Holding GmbH?
Five shareholders are currently on record for Adragos Pharma Holding GmbH, held on the Gesellschafterliste (shareholder list), filed under §40 of the GmbHG. The largest of these is Four Invest S.à r.l., holding 37.4% — the largest recorded stake — followed by Four Invest S.à r.l. at 35.7%; the remaining 3 shareholders shown hold smaller stakes. 2 shareholders shown are companies, so the ownership chain continues above this level for those holdings; the other 3 are recorded as direct individual holders, though the record carries no UBO/PSC flag confirming beneficial-owner status.
Who is Adragos Pharma Holding GmbH's UBO (Ultimate Beneficial Owner)?
At least one shareholder recorded for Adragos Pharma Holding GmbH is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).
How many shareholders does Adragos Pharma Holding GmbH have on record?
5 shareholders are shown on record for Adragos Pharma Holding GmbH. The register reports 12 in total; only the top 5 by holding are shown here.
What is Adragos Pharma Holding GmbH's company registration number?
Adragos Pharma Holding GmbH's registration number is HRB 282245 München, filed with Handelsregister (Commercial Register) in Germany. Its current status on the register is active.
Is Adragos Pharma Holding GmbH still an active company?
Adragos Pharma Holding GmbH's status on Handelsregister (Commercial Register) is listed as active.
What is Adragos Pharma Holding GmbH's registered address?
The registered address on file for Adragos Pharma Holding GmbH is München, Germany.
Who are the officers/directors of Adragos Pharma Holding GmbH?
Two of the 5 officer records shown for Adragos Pharma Holding GmbH are current appointments, filed with Handelsregister (Commercial Register). Andreas Raabe and Daniel Wigbers both serve as Geschäftsführer (managing director). The remaining 3 records shown (Philipp Dionys Eberhard Ziehr, Andreas Christian Raabe and 1 other) are former appointments that have since been resigned. Management authority at Adragos Pharma Holding GmbH sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does Adragos Pharma Holding GmbH have a parent company or subsidiaries?
Adragos Pharma Holding GmbH sits 2 levels below its ultimate parent, FSN CAPITAL VI L.P., registered in United Kingdom. 1 subsidiary is recorded beneath it, across 1 jurisdiction. Those 1 subsidiary spans Germany jurisdiction, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 1 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to Adragos Pharma Holding GmbH's ownership over time?
This profile reflects a point-in-time snapshot from Handelsregister (Commercial Register). Zavia's monitoring API can track changes to Adragos Pharma Holding GmbH's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access Adragos Pharma Holding GmbH's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including Germany, so records like Adragos Pharma Holding GmbH's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Handelsregister (Commercial Register) and was last synced on 6 October 2026.